Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02364180 · ClinicalTrials.gov registry record · NA
Electromyography in Patients on Chronic Pyridostigmine Therapy
A NA study, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02364180: Completed NA study, sponsored by University of Toledo Health Science Campus.
NCT02364180 is a NA study that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02364180, a NA study, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
We intend to measure evoked EMG at two sites in subjects who are chronically taking pyridostigmine.
Primary Outcome
Normally when a nerve is rapidly stimulated the successive Compound Muscle Action Potentials (CMAP) are of the same height. We are hoping to investigate if chronic pyridostigmine therapy reduces the margin of safety and hence the successive CMAPs may be smaller than the preceding ones.
Interventions
- DIAGNOSTIC_TEST Electromyography (EMG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02364180 record still lists
NCT02364180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Electromyography (EMG) is the first listed.
NCT02364180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02364180 about?
NCT02364180 is a clinical study titled "Electromyography in Patients on Chronic Pyridostigmine Therapy". We intend to measure evoked EMG at two sites in subjects who are chronically taking pyridostigmine.
What is the current status of trial NCT02364180?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-12. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02364180?
The interventions under investigation include: Electromyography (EMG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02364180?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02364180's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia